The Impact of Baseline Serum C-Reactive Protein and C-Reactive Protein Kinetics on the Prognosis of Metastatic Nasopharyngeal Carcinoma Patients Treated with Palliative Chemotherapy-Reference-Cited by-同舟云学术

The Impact of Baseline Serum C-Reactive Protein and C-Reactive Protein Kinetics on the Prognosis of Metastatic Nasopharyngeal Carcinoma Patients Treated with Palliative Chemotherapy

Published:2013-10-10 Issue:10 Volume:8 Page:e76958
ISSN:1932-6203
Container-title:PLoS ONE
language:en
Short-container-title:PLoS ONE

Author:

Xia Wei-Xiong,Ye Yan-Fang,Lu Xing,Wang Lin,Ke Liang-Ru,Zhang Hai-Bo,Roycik Mark D.,Yang Jing,Shi Jun-Li,Cao Ka-Jia,Guo Xiang,Xiang Yan-Qun

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference40 articles.

1. The prevalence and prevention of nasopharyngeal carcinoma in China;SM Cao;Chin J Cancer,2011

2. Is nasopharyngeal cancer really a "Cantonese cancer"?;JT Wee;Chin J Cancer,2010

3. Nasopharyngeal carcinoma;WI Wei;Lancet,2005

4. Retrospective Analysis of 5037 Patients with Nasopharyngeal Carcinoma Treated during 1976-1985 - Overall Survival and Patterns of Failure;AWM Lee;Int J Radiat Oncol Biol Phys,1992

5. The Effect of Loco-Regional Control on Distant Metastatic Dissemination in Carcinoma of the Nasopharynx - an Analysis of 1301 Patients;D Kwong;Int J Radiat Oncol Biol Phys,1994

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. C-Reactive Protein: Pathophysiology, Diagnosis, False Test Results and a Novel Diagnostic Algorithm for Clinicians;Diseases;2023-09-28

2. Survival impact of additional induction chemotherapy in nasopharyngeal carcinoma with chronic hepatitis B infection: a retrospective, bi-center study;Annals of Translational Medicine;2022-07

3. A Nomogram to Predict Survival in Patients With Locoregional Recurrent Nasopharyngeal Carcinoma Receiving Comprehensive Treatment;Frontiers in Oncology;2022-06-16

4. A Scoring System Based on Nutritional and Inflammatory Parameters to Predict the Efficacy of First-Line Chemotherapy and Survival Outcomes for De Novo Metastatic Nasopharyngeal Carcinoma;Journal of Inflammation Research;2021-03

5. Prognostic model for risk stratification of de novo metastatic nasopharyngeal carcinoma patients treated with chemotherapy followed by locoregional radiotherapy;ESMO Open;2021-02